Please turn JavaScript on
biotechstrategyblog icon

biotechstrategyblog

Follow Biotechstrategyblog's news and updates in a matter of seconds! We will deliver any update via email, phone or you can read them from here on the site on your own news page.

You can even combine different feeds with the feed for Biotechstrategyblog.

Subscribing and unsubscribing is fast, easy and risk free.

The whole service is free of cost.

Biotechstrategyblog: Biotech Strategy Blog Cancer Conferences New Products

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  0.31 / day

Message History

On January 1st, 2025 I wrote up a lot of research notes, including one on ADC companies in Europe to…

Read full story
There’s a limit built into one of oncology’s approved drugs no amount of dosing can push past. A rival spent…

Read full story
Every gold rush needs a genuine strike; not a rumour, or a promoted claim, but actual gold pulled from the…

Read full story
Every few years, immuno-oncology finds a new way to say the same hopeful thing: this time, we can wake up…

Read full story
For a long time, the post-lenalidomide, post-proteasome inhibitor, post-CD38 setting in multiple myeloma felt like a place where treatment decisions…

Read full story